At a glance
ClinicalIndex Comparison Record- ✓Meets DSM-IV criteria for PTSD due to Iraq military trauma
- ✓Speaks English
- ✓Healthy overall
- ✕History of mania, schizophrenia, or other psychoses
- ✕Suicidal ideation or behavior
- ✕Current alcohol or drug dependence
- ✕Pregnant or planning pregnancy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD
In Brief
A Phase 3 clinical trial evaluating D-Cycloserine, Alprazolam, and 2 other interventions for Stress Disorder, Post Traumatic. Completed, enrolled 156 participants across 1 site.
Detailed Summary
This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.
Study Details
Timeline
Interventions
D-Cycloserine doses will be 50 mg. There will be 5 pills total during study, each given 30 minutes prior to each VRE session.
Alprazolam doses will be 0.25 mg. There will be 5 pills total during study, each given 30 minutes prior to each VRE session.
VRE includes viewing scenes of virtual Iraq via a head mounted display. Other stimuli presented include sounds, smells and vibration. Each session will be 60 minutes with approximately 30 to 45 minutes of that wearing head mounted display.
Placebo will be administered in the same manner as the active drugs.